or, select a GWAS: 5-HTT brain serotonin transporter levels (Liu et al., 2011), 1 SNP Abdominal aortic aneurysm (2 studies combined), 3 SNPs Abdominal aortic aneurysm (Bown MJ et al., 2011), 1 SNP Abdominal aortic aneurysm (Gretarsdottir et al., 2010), 2 SNPs Acenocoumarol maintenance dosage (Teichert et al., 2009), 4 SNPs Activated partial thromboplastin time (Houlihan et al., 2010), 3 SNPs Acute lymphoblastic leukemia (4 studies combined), 35 SNPs Acute lymphoblastic leukemia (childhood) (Ellinghaus E et al., 2011), 11 SNPs Acute lymphoblastic leukemia (childhood) (Papaemmanuil et al., 2009), 3 SNPs Acute lymphoblastic leukemia (childhood) (Trevińo et al., 2009), 14 SNPs Acute lymphoblastic leukemia (childhood) (Yang JJ et al., 2012), 10 SNPs Adiponectin levels (9 studies combined), 44 SNPs Adiponectin levels (Chung CM et al., 2011), 1 SNP Adiponectin levels (Dastani Z et al., 2012), 31 SNPs Adiponectin levels (Heid et al., 2009), 1 SNP Adiponectin levels (Jee et al., 2010), 1 SNP Adiponectin levels (Ling et al., 2009), 2 SNPs Adiponectin levels (Morisaki H et al., 2011), 1 SNP Adiponectin levels (Qi L et al., 2011), 5 SNPs Adiponectin levels (Richards et al., 2009), 3 SNPs Adiponectin levels (Wu et al., 2010), 3 SNPs Adiposity (3 studies combined), 8 SNPs Adiposity (Kilpelainen TO et al., 2011), 3 SNPs Adiposity (Lindgren et al., 2009), 4 SNPs Adiposity (Plourde M et al., 2012), 1 SNP Adverse response to aromatase inhibitors (2 studies combined), 2 SNPs Adverse response to aromatase inhibitors (Ingle et al., 2010), 1 SNP Adverse response to aromatase inhibitors (Ingle et al., 2010), 1 SNP Adverse response to carbamapezine (McCormack et al., 2011), 1 SNP Adverse response to lamotrigine and phenytoin (McCormack M et al., 2012), 12 SNPs Age-related macular degeneration (9 studies combined), 36 SNPs Age-related macular degeneration (Arakawa S et al., 2011), 2 SNPs Age-related macular degeneration (Chen et al., 2010), 12 SNPs Age-related macular degeneration (Cipriani V et al., 2012), 6 SNPs Age-related macular degeneration (GA) (Sobrin L et al., 2012), 16 SNPs Age-related macular degeneration (Klein RJ et al., 2005), 1 SNP Age-related macular degeneration (Kopplin et al., 2010), 4 SNPs Age-related macular degeneration (Neale et al., 2010), 11 SNPs Age-related macular degeneration (wet) (Dewan et al., 2006), 1 SNP Age-related macular degeneration (Yu et al., 2011), 11 SNPs Aging (3 studies combined), 20 SNPs Aging (Edwards DR et al., 2012), 8 SNPs Aging (Poduslo et al., 2009), 1 SNP Aging (time to event) (Walter S et al., 2011), 11 SNPs AIDS (Clerc et al., 2009), 7 SNPs AIDS progression (2 studies combined), 10 SNPs AIDS progression (Limou et al., 2009), 3 SNPs AIDS progression (Troyer et al., 2011), 7 SNPs Airflow obstruction (Wilk JB et al., 2012), 30 SNPs Alcohol and nictotine co-dependence (Zuo L et al., 2012), 8 SNPs Alcohol consumption (3 studies combined), 11 SNPs Alcohol consumption (Baik et al., 2011), 4 SNPs Alcohol consumption (Kutalik Z et al., 2011), 6 SNPs Alcohol consumption (Schumann et al., 2011), 1 SNP Alcohol dependence (6 studies combined), 21 SNPs Alcohol dependence (Frank J et al., 2011), 6 SNPs Alcohol dependence (Kendler et al., 2011), 3 SNPs Alcohol dependence (Lydall GJ et al., 2011), 1 SNP Alcohol dependence (Treutlein et al., 2009), 6 SNPs Alcohol dependence (Wang KS et al., 2011), 2 SNPs Alcohol dependence (Zuo L et al., 2011), 3 SNPs Alcoholism (heaviness of drinking) (Heath et al., 2011), 22 SNPs Alopecia areata (Petukhova et al., 2010), 8 SNPs Alzheimer's disease (27 studies combined), 101 SNPs Alzheimer's disease (Abraham et al., 2008), 2 SNPs Alzheimer's disease (age of onset) (Kamboh MI et al., 2011), 12 SNPs Alzheimer's disease (Antunez et al., 2011), 5 SNPs Alzheimer's disease (Beecham et al., 2009), 3 SNPs Alzheimer's disease (Bertram et al., 2008), 2 SNPs Alzheimer's disease (Carrasquillo et al., 2009), 1 SNP Alzheimer's disease (Feulner et al., 2009), 1 SNP Alzheimer's disease (Harold et al., 2009), 3 SNPs Alzheimer's disease (Heinzen EL et al., 2009), 5 SNPs Alzheimer's disease (Heinzen et al., 2009), 5 SNPs Alzheimer's disease (Hollingworth et al., 2011), 4 SNPs Alzheimer's disease (Hollingworth P et al., 2011), 18 SNPs Alzheimer's disease (Kamboh MI et al., 2012), 8 SNPs Alzheimer's disease (Kramer et al., 2010), 2 SNPs Alzheimer's disease (Lambert et al., 2009), 3 SNPs Alzheimer's disease (Lambert JC et al., 2012), 1 SNP Alzheimer's disease (late onset) (Coon et al., 2007), 1 SNP Alzheimer's disease (late onset) (Cummings AC et al., 2012), 13 SNPs Alzheimer's disease (late onset) (Hu et al., 2011), 2 SNPs Alzheimer's disease (late onset) (Naj et al., 2010), 4 SNPs Alzheimer's disease (late onset) (Naj et al., 2011), 9 SNPs Alzheimer's disease (late onset) (Reiman et al., 2007), 1 SNP Alzheimer's disease (late onset) (Wijsman et al., 2011), 1 SNP Alzheimer's disease (Li et al., 2007), 1 SNP Alzheimer's disease (Logue MW et al., 2011), 11 SNPs Alzheimer's disease (Seshadri et al., 2010), 1 SNP Alzheimer's disease (Webster et al., 2007), 1 SNP Alzheimer's disease biomarkers (Kim et al., 2010), 7 SNPs Amyloid A Levels (Marzi et al., 2010), 3 SNPs Amyotrophic lateral sclerosis (11 studies combined), 66 SNPs Amyotrophic lateral sclerosis (age of onset) (Ahmeti KB et al., 2012), 28 SNPs Amyotrophic lateral sclerosis (Cronin et al., 2007), 1 SNP Amyotrophic lateral sclerosis (Cronin et al., 2008), 1 SNP Amyotrophic lateral sclerosis (Kwee LC et al., 2012), 2 SNPs Amyotrophic lateral sclerosis (Laaksovirta et al., 2010), 2 SNPs Amyotrophic lateral sclerosis (Landers et al., 2009), 16 SNPs Amyotrophic lateral sclerosis (Schymick et al., 2007), 6 SNPs Amyotrophic lateral sclerosis (Shatunov et al., 2010), 4 SNPs Amyotrophic lateral sclerosis (van Es et al., 2007), 3 SNPs Amyotrophic lateral sclerosis (van Es et al., 2007), 1 SNP Amyotrophic lateral sclerosis (van Es et al., 2009), 8 SNPs Androgen levels (Jin G et al., 2012), 6 SNPs Angiotensin-converting enzyme activity (Chung et al., 2010), 2 SNPs Ankle-brachial index (Murabito JM et al., 2011), 2 SNPs Ankylosing spondylitis (3 studies combined), 25 SNPs Ankylosing spondylitis (Evans DM et al., 2011), 13 SNPs Ankylosing spondylitis (Lin Z et al., 2011), 5 SNPs Ankylosing spondylitis (Reveille et al., 2010), 9 SNPs Anorexia nervosa (Wang et al., 2010), 9 SNPs Anthropometric traits (Polasek et al., 2009), 12 SNPs Anti-cyclic Citrullinated Peptide Antibody (Cui et al., 2009), 1 SNP Anticoagulant levels (Athanasiadis G et al., 2011), 8 SNPs Antineutrophil cytoplasmic antibody-associated vasculitis (Lyons PA et al., 2012), 18 SNPs Antipsychotic drug-induced weight gain (Malhotra AK et al., 2012), 1 SNP Antipsychotic-induced QTc interval prolongation (Aberg et al., 2010), 3 SNPs Aortic root size (Wineinger et al., 2011), 7 SNPs Aortic stiffness (Mitchell GF et al., 2011), 1 SNP Arterial stiffness (Tarasov et al., 2009), 1 SNP Arthritis (3 studies combined), 6 SNPs Arthritis (juvenile idiopathic) (Behrens et al., 2008), 1 SNP Arthritis (juvenile idiopathic) (Hinks et al., 2009), 1 SNP Arthritis (juvenile idiopathic) (Thompson SD et al., 2012), 4 SNPs Aspartate aminotransferase (Shen H et al., 2011), 1 SNP Asperger disorder (Salyakina et al., 2010), 5 SNPs Asthma (17 studies combined), 62 SNPs Asthma (bronchodilator response) (Himes BE et al., 2012), 1 SNP Asthma (childhood onset) (Forno E et al., 2012), 5 SNPs Asthma (childhood onset) (Hancock et al., 2009), 1 SNP Asthma (Ferreira et al., 2010), 1 SNP Asthma (Ferreira MA et al., 2011), 4 SNPs Asthma (Himes et al., 2009), 1 SNP Asthma (Hirota T et al., 2011), 14 SNPs Asthma (Li et al., 2010), 3 SNPs Asthma (Moffatt et al., 2007), 1 SNP Asthma (Moffatt et al., 2010), 10 SNPs Asthma (Noguchi E et al., 2011), 2 SNPs Asthma (Ramasamy A et al., 2012), 2 SNPs Asthma (Sleiman et al., 2009), 1 SNP Asthma (Tantisira KG et al., 2012), 1 SNP Asthma (toluene diisocyanate-induced) (Kim et al., 2009), 3 SNPs Asthma (Torgerson DG et al., 2011), 7 SNPs Asthma (Wan YI et al., 2012), 6 SNPs Atopic dermatitis (4 studies combined), 25 SNPs Atopic dermatitis (Esparza-Gordillo et al., 2009), 1 SNP Atopic dermatitis (Hirota T et al., 2012), 17 SNPs Atopic dermatitis (Paternoster L et al., 2011), 6 SNPs Atopic dermatitis (Sun et al., 2011), 1 SNP Atopy (Castro-Giner et al., 2009), 1 SNP Atrial fibrillation (4 studies combined), 17 SNPs Atrial fibrillation (Benjamin et al., 2009), 3 SNPs Atrial fibrillation (Ellinor et al., 2010), 3 SNPs Atrial fibrillation (Ellinor PT et al., 2012), 10 SNPs Atrial fibrillation (Gudbjartsson et al., 2009), 2 SNPs Atrial fibrillation/atrial flutter (Gudbjartsson et al., 2007), 2 SNPs Atrioventricular conduction (Denny et al., 2010), 5 SNPs Attention deficit hyperactivity disorder (6 studies combined), 58 SNPs Attention deficit hyperactivity disorder (Hinney A et al., 2011), 2 SNPs Attention deficit hyperactivity disorder (Lesch et al., 2008), 26 SNPs Attention deficit hyperactivity disorder (Mick E et al., 2011), 7 SNPs Attention deficit hyperactivity disorder (Mick et al., 2008), 2 SNPs Attention deficit hyperactivity disorder (Mick et al., 2010), 10 SNPs Attention deficit hyperactivity disorder (time to onset) (Lasky-Su et al., 2008), 11 SNPs Attention deficit hyperactivity disorder and conduct disorder (Anney et al., 2008), 26 SNPs Attention deficit hyperactivity disorder motor coordination (Fliers et al., 2011), 1 SNP Autism (5 studies combined), 9 SNPs Autism (Anney et al., 2010), 2 SNPs Autism (Anney R et al., 2012), 4 SNPs Autism (Ma et al., 2009), 1 SNP Autism (Wang et al., 2009), 1 SNP Autism (Weiss et al., 2009), 1 SNP Barrett's esophagus (Su Z et al., 2012), 5 SNPs Basal cell carcinoma (Nan H et al., 2011), 3 SNPs Basal cell carcinoma (cutaneous) (Stacey et al., 2008), 2 SNPs Behcet's disease (3 studies combined), 10 SNPs Behcet's disease (Hou S et al., 2012), 6 SNPs Behcet's disease (Mizuki et al., 2010), 2 SNPs Behcet's disease (Remmers et al., 2010), 2 SNPs Beta thalassemia/hemoglobin E disease (Nuinoon et al., 2009), 3 SNPs Biliary atresia (Garcia-Barceló et al., 2010), 3 SNPs Bilirubin levels (3 studies combined), 16 SNPs Bilirubin levels (Bielinski et al., 2011), 5 SNPs Bilirubin levels (Chen G et al., 2011), 9 SNPs Bilirubin levels (Sanna et al., 2009), 3 SNPs Biochemical measures (Zemunik et al., 2009), 17 SNPs Bipolar disorder (15 studies combined), 129 SNPs Bipolar disorder (age of onset and psychomotor symptoms) (Mahon et al., 2011), 2 SNPs Bipolar disorder (Baum et al., 2007), 1 SNP Bipolar disorder (Chen DT et al., 2011), 5 SNPs Bipolar disorder (Cichon et al., 2011), 1 SNP Bipolar disorder (Ferreira et al., 2008), 21 SNPs Bipolar disorder (Jiang Y et al., 2011), 24 SNPs Bipolar disorder (Kerner B et al., 2011), 3 SNPs Bipolar disorder (Lee et al., 2010), 2 SNPs Bipolar disorder (Lee HJ et al., 2012), 15 SNPs Bipolar disorder (mood-incongruent) (Goes FS et al., 2012), 16 SNPs Bipolar disorder (Scott et al., 2009), 13 SNPs Bipolar disorder (Sklar P et al., 2011), 18 SNPs Bipolar disorder (Smith EN et al., 2011), 6 SNPs Bipolar disorder (Smith et al., 2009), 1 SNP Bipolar disorder (Yosifova A et al., 2011), 3 SNPs Bipolar disorder and major depressive disorder (combined) (Liu et al., 2010), 9 SNPs Bipolar disorder and schizophrenia (2 studies combined), 56 SNPs Bipolar disorder and schizophrenia (Curtis et al., 2010), 6 SNPs Bipolar disorder and schizophrenia (Wang et al., 2010), 50 SNPs Birth weight (Freathy et al., 2010), 2 SNPs Bitter taste response (Reed et al., 2010), 1 SNP Black vs. red hair color (Han et al., 2008), 14 SNPs Bladder cancer (4 studies combined), 11 SNPs Bladder cancer (Garcia-Closas M et al., 2011), 1 SNP Bladder cancer (Rafnar T et al., 2011), 1 SNP Bladder cancer (Rothman et al., 2010), 9 SNPs Bladder cancer (Wu et al., 2009), 1 SNP Bleomycin sensitivity (Gu et al., 2010), 3 SNPs Blood lipid traits (Teslovich et al., 2010), 2 SNPs Blood pressure (4 studies combined), 48 SNPs Blood pressure (Kato N et al., 2011), 17 SNPs Blood pressure (Wain LV et al., 2011), 41 SNPs Blood pressure (Wang et al., 2008), 1 SNP Blood pressure (Zhang D et al., 2012), 4 SNPs Body mass (lean) (Liu et al., 2009), 1 SNP Body mass in chronic obstructive pulmonary disease (Wan et al., 2010), 1 SNP Body mass index (9 studies combined), 70 SNPs Body mass index (Frayling et al., 2007), 1 SNP Body mass index (Loos et al., 2008), 2 SNPs Body mass index (Ng MC et al., 2011), 2 SNPs Body mass index (Okada Y et al., 2012), 10 SNPs Body mass index (Speliotes et al., 2010), 38 SNPs Body mass index (Wang KS et al., 2012), 3 SNPs Body mass index (Wen W et al., 2012), 7 SNPs Body mass index (Willer et al., 2008), 11 SNPs Body mass index (Yang J et al., 2012), 1 SNP Body mass index and cholesterol (psychopharmacological treatment) (Athanasiu L et al., , 2 SNPs Bone mineral density (10 studies combined), 59 SNPs Bone mineral density (Duncan et al., 2011), 9 SNPs Bone mineral density (Guo et al., 2009), 2 SNPs Bone mineral density (Kung et al., 2010), 1 SNP Bone mineral density (Medina-Gomez C et al., 2012), 2 SNPs Bone mineral density (Paternoster et al., 2010), 1 SNP Bone mineral density (Richards et al., 2008), 2 SNPs Bone mineral density (spine) (Rivadeneira et al., 2009), 29 SNPs Bone mineral density (spine) (Styrkarsdottir et al., 2008), 15 SNPs Bone mineral density (spine) (Styrkarsdottir et al., 2008), 14 SNPs Bone mineral density (Xiong et al., 2009), 2 SNPs Brachial circumference (Boraska V et al., 2012), 1 SNP Brain imaging (Shen et al., 2010), 10 SNPs Brain imaging in schizophrenia (interaction) (Potkin et al., 2008), 6 SNPs Brain structure (2 studies combined), 21 SNPs Brain structure (Stein et al., 2010), 19 SNPs Brain structure (Stein JL et al., 2012), 2 SNPs Breast cancer (23 studies combined), 53 SNPs Breast cancer (Antoniou et al., 2010), 1 SNP Breast cancer (Cai Q et al., 2011), 2 SNPs Breast cancer (Chen F et al., 2012), 1 SNP Breast cancer (Easton et al., 2007), 6 SNPs Breast cancer (Elgazzar S et al., 2012), 2 SNPs Breast cancer (Fletcher et al., 2011), 9 SNPs Breast cancer (Gaudet et al., 2010), 1 SNP Breast cancer (Gold et al., 2008), 1 SNP Breast cancer (Haiman CA et al., 2011), 1 SNP Breast cancer (Hunter et al., 2007), 1 SNP Breast cancer (Kibriya et al., 2008), 1 SNP Breast cancer (Kim HC et al., 2012), 1 SNP Breast cancer (Li et al., 2010), 4 SNPs Breast cancer (Long et al., 2010), 1 SNP Breast cancer (Long J et al., 2012), 3 SNPs Breast cancer (male) (Orr N et al., 2012), 3 SNPs Breast cancer (Sehrawat et al., 2011), 2 SNPs Breast cancer (Siddiq A et al., 2012), 4 SNPs Breast cancer (Stacey et al., 2007), 2 SNPs Breast cancer (survival) (Shu XO et al., 2012), 3 SNPs Breast cancer (Thomas et al., 2009), 6 SNPs Breast cancer (Turnbull et al., 2010), 13 SNPs Breast cancer (Zheng et al., 2009), 1 SNP Breast size (Eriksson N et al., 2012), 31 SNPs Butyrylcholinesterase levels (Benyamin B et al., 2011), 3 SNPs C-reactive protein (8 studies combined), 46 SNPs C-reactive protein (Dehghan et al., 2011), 20 SNPs C-reactive protein (Doumatey AP et al., 2012), 1 SNP C-reactive protein (Elliott et al., 2009), 5 SNPs C-reactive protein (Okada et al., 2010), 4 SNPs C-reactive protein (Reiner AP et al., 2012), 11 SNPs C-reactive protein (Reiner et al., 2008), 3 SNPs C-reactive protein (Ridker et al., 2008), 7 SNPs C-reactive protein (Wu et al., 2011), 3 SNPs C-reactive protein and white blood cell count (Kong M et al., 2012), 9 SNPs Caffeine consumption (Cornelis et al., 2011), 10 SNPs Cannabis dependence (Agrawal A et al., 2010), 10 SNPs Cannbis use (initiation) (Verweij KJ et al., 2012), 6 SNPs Capecitabine sensitivity (O'Donnell PH et al., 2012), 22 SNPs Cardiac hypertrophy (Parsa et al., 2011), 19 SNPs Cardiac repolarization (2 studies combined), 4 SNPs Cardiac repolarization (Marjamaa A et al., 2012), 1 SNP Cardiac repolarization (Sinner MF et al., 2012), 3 SNPs Cardiac structure and function (Vasan et al., 2009), 10 SNPs Cardiovascular disease risk factors (4 studies combined), 30 SNPs Cardiovascular disease risk factors (Middelberg RP et al., 2011), 19 SNPs Cardiovascular disease risk factors (Reilly et al., 2011), 2 SNPs Cardiovascular disease risk factors (Schurks M et al., 2011), 5 SNPs Cardiovascular disease risk factors (Smith et al., 2010), 6 SNPs Carotid atherosclerosis in HIV infection (Shrestha et al., 2010), 7 SNPs Carotid intima media thickness (Bis JC et al., 2011), 11 SNPs Caudate nucleus volume (Stein et al., 2011), 2 SNPs CD4:CD8 lymphocyte ratio (Ferreira et al., 2009), 2 SNPs Celiac disease (3 studies combined), 43 SNPs Celiac disease (Dubois et al., 2010), 40 SNPs Celiac disease (Hunt et al., 2008), 8 SNPs Celiac disease (van Heel et al., 2007), 2 SNPs Celiac disease and Rheumatoid arthritis (Zhernakova et al., 2011), 15 SNPs Central corneal thickness (3 studies combined), 8 SNPs Central corneal thickness (Hoehn R et al., 2012), 2 SNPs Central corneal thickness (Lu et al., 2010), 2 SNPs Central corneal thickness (Vitart et al., 2010), 5 SNPs Cholelithiasis-related traits in sickle cell anemia (Milton JN et al., 2012), 1 SNP Cholesterol (Igl et al., 2010), 1 SNP Cholesterol and Triglycerides (Surakka I et al., 2012), 4 SNPs Chronic Hepatitis C infection (3 studies combined), 4 SNPs Chronic Hepatitis C infection (Fellay J et al., 2010), 2 SNPs Chronic Hepatitis C infection (Miki D et al., 2011), 1 SNP Chronic Hepatitis C infection (Rauch et al., 2010), 1 SNP Chronic kidney disease (2 studies combined), 30 SNPs Chronic kidney disease (Köttgen et al., 2010), 28 SNPs Chronic kidney disease (Pattaro C et al., 2012), 2 SNPs Chronic kidney disease and serum creatinine levels (Gudbjartsson et al., 2010), 4 SNPs Chronic lymphocytic leukemia (4 studies combined), 18 SNPs Chronic lymphocytic leukemia (Bernardo et al., 2008), 6 SNPs Chronic lymphocytic leukemia (Crowther-Swanepoel et al., 2010), 7 SNPs Chronic lymphocytic leukemia (Slager et al., 2010), 4 SNPs Chronic lymphocytic leukemia (Slager SL et al., 2012), 8 SNPs Chronic myeloid leukemia (Kim et al., 2011), 2 SNPs Chronic obstructive pulmonary disease (4 studies combined), 21 SNPs Chronic obstructive pulmonary disease (Cho et al., 2010), 3 SNPs Chronic obstructive pulmonary disease (Cho MH et al., 2011), 4 SNPs Chronic obstructive pulmonary disease (Pillai et al., 2009), 2 SNPs Chronic obstructive pulmonary disease (Siedlinski M et al., 2011), 12 SNPs Circulating cell-free DNA (Jylhava J et al., 2012), 1 SNP Cleft lip (Beaty et al., 2010), 2 SNPs Coffee consumption (2 studies combined), 6 SNPs Coffee consumption (Amin N et al., 2011), 4 SNPs Coffee consumption (Sulem et al., 2011), 2 SNPs Cognitive decline (De Jager PL et al., 2011), 1 SNP Cognitive function (LeBlanc M et al., 2011), 2 SNPs Cognitive performance (Need et al., 2009), 47 SNPs Cognitive test performance (Cirulli et al., 2010), 50 SNPs Colorectal cancer (10 studies combined), 22 SNPs Colorectal cancer (Broderick et al., 2007), 1 SNP Colorectal cancer (Cui et al., 2011), 2 SNPs Colorectal cancer (Dunlop MG et al., 2012), 3 SNPs Colorectal cancer (Houlston et al., 2008), 4 SNPs Colorectal cancer (Houlston et al., 2010), 5 SNPs Colorectal cancer (Peters U et al., 2011), 5 SNPs Colorectal cancer (Tenesa et al., 2008), 3 SNPs Colorectal cancer (Tomlinson et al., 2007), 1 SNP Colorectal cancer (Tomlinson et al., 2008), 5 SNPs Colorectal cancer (Zanke et al., 2007), 1 SNP Complement C3 and C4 levels (Yang X et al., 2012), 10 SNPs Comprehensive strength and appendicular lean mass (Han Y et al., 2012), 2 SNPs Conduct disorder (2 studies combined), 45 SNPs Conduct disorder (interaction) (Sonuga-Barke et al., 2008), 22 SNPs Conduct disorder (symptom count) (Dick et al., 2010), 26 SNPs Corneal astigmatism (Fan Q et al., 2011), 6 SNPs Corneal curvature (2 studies combined), 12 SNPs Corneal curvature (Han et al., 2011), 2 SNPs Corneal curvature (Mishra A et al., 2012), 10 SNPs Corneal structure (Li X et al., 2011), 5 SNPs Coronary artery calcification (O'Donnell CJ et al., 2011), 3 SNPs Coronary heart disease (13 studies combined), 118 SNPs Coronary heart disease (Davies RW et al., 2012), 5 SNPs Coronary heart disease (Erdmann et al., 2009), 2 SNPs Coronary heart disease (Erdmann et al., 2010), 1 SNP Coronary heart disease (Genetics et al., 2011), 19 SNPs Coronary heart disease (Hager J et al., 2012), 3 SNPs Coronary heart disease (Lettre et al., 2011), 44 SNPs Coronary heart disease (Lu X et al., 2012), 8 SNPs Coronary heart disease (Mehta NN et al., 2011), 2 SNPs Coronary heart disease (Samani et al., 2007), 7 SNPs Coronary heart disease (Schunkert et al., 2011), 30 SNPs Coronary heart disease (Takeuchi F et al., 2011), 3 SNPs Coronary heart disease (Trégouët et al., 2009), 2 SNPs Coronary heart disease (Wild et al., 2011), 5 SNPs Coronary restenosis (Sampietro ML et al., 2011), 1 SNP Coronary spasm (Suzuki et al., 2007), 1 SNP Cortical structure (Bakken TE et al., 2012), 1 SNP Cortical thickness (2 studies combined), 4 SNPs Cortical thickness (Bakken TE et al., 2011), 1 SNP Cortical thickness (Zheng HF et al., 2012), 3 SNPs Creutzfeldt-Jakob disease (2 studies combined), 8 SNPs Creutzfeldt-Jakob disease (Mead et al., 2008), 2 SNPs Creutzfeldt-Jakob disease (variant) (Sanchez-Juan P et al., 2011), 6 SNPs Crohn's disease (10 studies combined), 113 SNPs Crohn's disease (Barrett et al., 2008), 30 SNPs Crohn's disease (Franke et al., 2007), 3 SNPs Crohn's disease (Franke et al., 2010), 50 SNPs Crohn's disease (Julia A et al., 2012), 10 SNPs Crohn's disease (Kenny EE et al., 2012), 17 SNPs Crohn's disease (Libioulle et al., 2007), 3 SNPs Crohn's disease (McGovern et al., 2010), 7 SNPs Crohn's disease (Parkes et al., 2007), 9 SNPs Crohn's disease (Raelson et al., 2007), 3 SNPs Crohn's disease (Rioux et al., 2007), 4 SNPs Crohn's disease and Celiac disease (Festen et al., 2011), 2 SNPs Crohn's disease and psoriasis (Ellinghaus D et al., 2012), 4 SNPs Crohn's disease and sarcoidosis (combined) (Franke et al., 2008), 1 SNP Cutaneous nevi (2 studies combined), 5 SNPs Cutaneous nevi (Falchi et al., 2009), 2 SNPs Cutaneous nevi (Nan et al., 2011), 3 SNPs Cystic fibrosis severity (Wright et al., 2011), 6 SNPs Cytomegalovirus antibody response (Kuparinen T et al., 2011), 9 SNPs D-dimer levels (Smith et al., 2011), 15 SNPs Dengue shock syndrome (Khor CC et al., 2011), 4 SNPs Dental caries (Shaffer JR et al., 2011), 3 SNPs Depression and alcohol dependence (Edwards AC et al., 2011), 8 SNPs Depression--quantitative trait (Terracciano et al., 2010), 11 SNPs Diabetes (gestational) (Kwak SH et al., 2012), 3 SNPs Diabetic nephropathy (2 studies combined), 6 SNPs Diabetic nephropathy (Maeda et al., 2007), 1 SNP Diabetic nephropathy (McDonough et al., 2010), 5 SNPs Diabetic retinopathy (2 studies combined), 27 SNPs Diabetic retinopathy (Grassi et al., 2011), 19 SNPs Diabetic retinopathy (Huang et al., 2011), 8 SNPs Dialysis-related mortality (Murea et al., 2011), 26 SNPs Digit length ratio (Medland et al., 2010), 1 SNP Dilated cardiomyopathy (Villard et al., 2011), 2 SNPs Disc degeneration (lumbar) (Williams FM et al., 2012), 35 SNPs Drinking behavior (Takeuchi et al., 2011), 2 SNPs Drug-induced liver injury (Urban TJ et al., 2012), 1 SNP Drug-induced liver injury (2 studies combined), 8 SNPs Drug-induced liver injury (amoxicillin-clavulanate) (Lucena et al., 2011), 2 SNPs Drug-induced liver injury (flucloxacillin) (Daly et al., 2009), 6 SNPs Duodenal ulcer (Tanikawa C et al., 2012), 2 SNPs Dupuytren's disease (2 studies combined), 13 SNPs Dupuytren's disease (Dolmans GH et al., 2011), 12 SNPs Dupuytren's disease (Ojwang et al., 2010), 1 SNP Eating disorders (Boraska V et al., 2012), 7 SNPs Economic and political preferences (time) (Benjamin DJ et al., 2012), 53 SNPs Electrocardiographic conduction measures (Smith et al., 2009), 7 SNPs Electrocardiographic traits (2 studies combined), 17 SNPs Electrocardiographic traits (Chambers et al., 2010), 3 SNPs Electrocardiographic traits (Holm et al., 2010), 18 SNPs Electroencephalographic traits in alcoholism (Kang SJ et al., 2012), 8 SNPs Emphysema-related traits (Kong et al., 2010), 7 SNPs End-stage renal disease (2 studies combined), 2 SNPs End-stage renal disease (Hanson et al., 2007), 1 SNP End-stage renal disease (non-diabetic) (Bostrom et al., 2010), 1 SNP Endometrial cancer (Spurdle et al., 2011), 2 SNPs Endometriosis (3 studies combined), 7 SNPs Endometriosis (Adachi et al., 2010), 2 SNPs Endometriosis (Painter et al., 2010), 3 SNPs Endometriosis (Uno et al., 2010), 2 SNPs Eosinophilic esophagitis (pediatric) (Rothenberg et al., 2010), 14 SNPs Epilepsy (2 studies combined), 11 SNPs Epilepsy (generalized) (EPICURE Consortium et al., 2012), 10 SNPs Epilepsy (Guo Y et al., 2011), 1 SNP Epirubicin-induced leukopenia (Srinivasan Y et al., 2011), 2 SNPs Erectile dysfunction (Hotaling JM et al., 2012), 6 SNPs Erectile dysfunction and prostate cancer treatment (Kerns et al., 2010), 23 SNPs Erythrocyte sedimentation rate (Kullo IJ et al., 2011), 5 SNPs Esophageal cancer (3 studies combined), 24 SNPs Esophageal cancer (Cui et al., 2009), 2 SNPs Esophageal cancer (squamous cell) (Wu C et al., 2012), 11 SNPs Esophageal cancer (Wu et al., 2011), 11 SNPs Esophageal cancer and gastric cancer (Abnet et al., 2010), 4 SNPs Essential tremor (2 studies combined), 2 SNPs Essential tremor (Stefansson et al., 2009), 1 SNP Essential tremor (Thier S et al., 2012), 1 SNP Event-related brain oscillations (2 studies combined), 3 SNPs Event-related brain oscillations (Zlojutro et al., 2010), 3 SNPs Event-related brain oscillations (Zlojutro M et al., 2010), 3 SNPs Ewing sarcoma (Postel-Vinay S et al., 2012), 3 SNPs Exercise (leisure time) (Moor et al., 2009), 3 SNPs Exercise treadmill test traits (Vasan et al., 2007), 13 SNPs Eye color traits (Liu et al., 2010), 3 SNPs F-cell distribution (2 studies combined), 12 SNPs F-cell distribution (Bhatnagar et al., 2011), 11 SNPs F-cell distribution (Menzel et al., 2007), 2 SNPs Facial morphology (Paternoster L et al., 2012), 1 SNP Fasting insulin-related traits (2 studies combined), 51 SNPs Fasting insulin-related traits (Dupuis et al., 2010), 34 SNPs Fasting insulin-related traits (interaction with BMI) (Manning AK et al., 2012), 51 SNPs Fasting plasma glucose (7 studies combined), 14 SNPs Fasting plasma glucose (Bouatia-Naji et al., 2008), 1 SNP Fasting plasma glucose (Bouatia-Naji et al., 2008), 1 SNP Fasting plasma glucose (Chambers et al., 2009), 1 SNP Fasting plasma glucose (Chen et al., 2008), 1 SNP Fasting plasma glucose (Meigs et al., 2007), 11 SNPs Fasting plasma glucose (Prokopenko et al., 2008), 3 SNPs Fasting plasma glucose (Rasmussen-Torvik LJ et al., 2012), 3 SNPs Femoral neck bone geometry (Sun L et al., 2011), 2 SNPs Fetal hemoglobin levels (Uda et al., 2008), 2 SNPs Fibrinogen (3 studies combined), 15 SNPs Fibrinogen (Danik et al., 2009), 6 SNPs Fibrinogen (Dehghan et al., 2009), 4 SNPs Fibrinogen (Lovely RS et al., 2011), 5 SNPs Folate pathway vitamin levels (Tanaka et al., 2009), 5 SNPs Follicular lymphoma (3 studies combined), 4 SNPs Follicular lymphoma (Conde et al., 2010), 3 SNPs Follicular lymphoma (Skibola et al., 2009), 1 SNP Follicular lymphoma (Smedby et al., 2011), 1 SNP Formal thought disorder in schizophrenia (Wang KS et al., 2012), 5 SNPs Fuchs's corneal dystrophy (Baratz et al., 2010), 2 SNPs Functional MRI (Liu et al., 2010), 2 SNPs Gallbladder cancer (Cha PC et al., 2012), 5 SNPs Gallstones (Buch et al., 2007), 1 SNP Gambling (Lind PA et al., 2012), 5 SNPs Gamma gluatamyl transferase levels (interaction with age) (Middelberg RP et al., 2011), 4 SNPs Gastric cancer (Shi Y et al., 2011), 2 SNPs Gaucher disease severity (Zhang CK et al., 2012), 3 SNPs Glaucoma (9 studies combined), 18 SNPs Glaucoma (Burdon et al., 2011), 2 SNPs Glaucoma (exfoliation) (Thorleifsson et al., 2007), 1 SNP Glaucoma (Meguro et al., 2010), 2 SNPs Glaucoma (primary open-angle) (Nakano M et al., 2012), 1 SNP Glaucoma (primary open-angle) (Osman W et al., 2012), 3 SNPs Glaucoma (primary open-angle) (Thorleifsson et al., 2010), 1 SNP Glaucoma (primary open-angle) (Vithana EN et al., 2012), 5 SNPs Glaucoma (primary open-angle) (Wiggs JL et al., 2012), 4 SNPs Glaucoma (Takamoto M et al., 2012), 1 SNP Glioblastoma (Xiao Y et al., 2012), 1 SNP Glioma (5 studies combined), 12 SNPs Glioma (high-grade) (Wrensch et al., 2009), 3 SNPs Glioma (Rajaraman P et al., 2012), 3 SNPs Glioma (Sanson et al., 2011), 7 SNPs Glioma (Shete et al., 2009), 7 SNPs Glioma (Yang TH et al., 2011), 1 SNP Glomerulosclerosis (Genovese et al., 2010), 1 SNP Glycated hemoglobin levels (4 studies combined), 17 SNPs Glycated hemoglobin levels (Franklin et al., 2010), 1 SNP Glycated hemoglobin levels (Paré et al., 2008), 4 SNPs Glycated hemoglobin levels (Ryu J et al., 2012), 1 SNP Glycated hemoglobin levels (Soranzo et al., 2010), 11 SNPs Graves' disease (2 studies combined), 18 SNPs Graves' disease (Chu X et al., 2011), 11 SNPs Graves' disease (Nakabayashi K et al., 2011), 7 SNPs Hair color (2 studies combined), 30 SNPs Hair color (Eriksson et al., 2010), 40 SNPs Hair color (Kenny EE et al., 2012), 1 SNP Hair morphology (Medland et al., 2009), 15 SNPs Handedness in dyslexia (Scerri et al., 2010), 1 SNP Haptoglobin levels (Froguel P et al., 2012), 1 SNP HbA2 levels (Menzel S et al., 2012), 2 SNPs HDL cholesterol (2 studies combined), 4 SNPs HDL cholesterol (Heid et al., 2008), 3 SNPs HDL cholesterol (Ridker et al., 2009), 1 SNP Head circumference (infant) (Taal HR et al., 2012), 3 SNPs Hearing impairment (Laer et al., 2010), 2 SNPs Heart failure (Smith et al., 2010), 16 SNPs Heart rate variability traits (2 studies combined), 6 SNPs Heart rate variability traits (Newton-Cheh et al., 2007), 4 SNPs Heart rate variability traits (Rankinen T et al., 2011), 2 SNPs Height (18 studies combined), 242 SNPs Height (Allen et al., 2010), 50 SNPs Height (Carty CL et al., 2011), 8 SNPs Height (Cho et al., 2009), 13 SNPs Height (Estrada et al., 2009), 5 SNPs Height (Gudbjartsson et al., 2008), 52 SNPs Height (Johansson et al., 2008), 1 SNP Height (Kim et al., 2009), 15 SNPs Height (Kim et al., 2010), 1 SNP Height (Lei et al., 2008), 1 SNP Height (Lettre et al., 2008), 18 SNPs Height (Liu et al., 2010), 10 SNPs Height (N'Diaye A et al., 2011), 33 SNPs Height (Okada et al., 2010), 25 SNPs Height (Sanna et al., 2008), 5 SNPs Height (Soranzo et al., 2009), 20 SNPs Height (Tönjes et al., 2009), 1 SNP Height (Weedon et al., 2007), 1 SNP Height (Weedon et al., 2008), 20 SNPs Hematological and biochemical traits (Kamatani et al., 2010), 50 SNPs Hematology traits (Ferreira et al., 2009), 6 SNPs Hemoglobin (Chambers et al., 2009), 2 SNPs Hemostatic factors and hematological phenotypes (2 studies combined), 31 SNPs Hemostatic factors and hematological phenotypes (Oudot-Mellakh T et al., 2012), 9 SNPs Hemostatic factors and hematological phenotypes (Yang et al., 2007), 22 SNPs Hepatitis B (4 studies combined), 5 SNPs Hepatitis B (Kamatani et al., 2009), 1 SNP Hepatitis B (Liu L et al., 2011), 1 SNP Hepatitis B (Mbarek H et al., 2011), 4 SNPs Hepatitis B (viral clearance) (Nishida N et al., 2012), 4 SNPs Hepatitis B vaccine response (Png E et al., 2011), 3 SNPs Hepatitis C induced liver fibrosis (Patin E et al., 2012), 6 SNPs Hepatocellular carcinoma (4 studies combined), 9 SNPs Hepatocellular carcinoma (Clifford et al., 2010), 3 SNPs Hepatocellular carcinoma (Kumar et al., 2011), 2 SNPs Hepatocellular carcinoma (Li S et al., 2012), 3 SNPs Hepatocellular carcinoma (Zhang et al., 2010), 1 SNP Hepcidin levels (Traglia M et al., 2011), 8 SNPs Hip bone size (Liu et al., 2008), 1 SNP Hip geometry (Kiel et al., 2007), 24 SNPs Hippocampal atrophy (2 studies combined), 31 SNPs Hippocampal atrophy (Melville SA et al., 2012), 10 SNPs Hippocampal atrophy (Potkin et al., 2009), 21 SNPs Hippocampal volume (Bis JC et al., 2012), 5 SNPs Hirschsprung's disease (Garcia-Barcelo et al., 2009), 2 SNPs HIV-1 control (3 studies combined), 55 SNPs HIV-1 control (Fellay et al., 2009), 42 SNPs HIV-1 control (Pelak et al., 2010), 10 SNPs HIV-1 control (Pereyra et al., 2010), 8 SNPs HIV-1 replication (Bol et al., 2011), 1 SNP HIV-1 susceptibility (Petrovski et al., 2010), 6 SNPs HIV-1 viral setpoint (Lingappa JR et al., 2011), 23 SNPs HIV-associated dementia (Levine AJ et al., 2012), 4 SNPs Hoarding (2 studies combined), 3 SNPs Hoarding (Perroud et al., 2010), 3 SNPs Hoarding (Perroud N et al., 2010), 3 SNPs Hodgkin's lymphoma (2 studies combined), 9 SNPs Hodgkin's lymphoma (Enciso-Mora et al., 2010), 5 SNPs Hodgkin's lymphoma (Urayama KY et al., 2012), 4 SNPs Homocysteine levels (Lange et al., 2010), 1 SNP HPV seropositivity (Chen D et al., 2011), 1 SNP Hypertension (6 studies combined), 22 SNPs Hypertension (Adeyemo et al., 2009), 2 SNPs Hypertension (Guo Y et al., 2012), 3 SNPs Hypertension (Org et al., 2009), 1 SNP Hypertension (Padmanabhan et al., 2010), 1 SNP Hypertension (Slavin et al., 2011), 14 SNPs Hypertension (young onset) (Yang et al., 2009), 1 SNP Hypertension risk in short sleep duration (Kim SJ et al., 2012), 3 SNPs Hypertriglyceridemia (Johansen et al., 2010), 5 SNPs Hypospadias (Zanden et al., 2010), 1 SNP Hypothyroidism (2 studies combined), 20 SNPs Hypothyroidism (Denny JC et al., 2011), 1 SNP Hypothyroidism (Eriksson N et al., 2012), 19 SNPs Idiopathic pulmonary fibrosis (Mushiroda et al., 2008), 1 SNP IFN-related cytopenia (Thompson AJ et al., 2011), 1 SNP IgA levels (Yang C et al., 2012), 1 SNP IgA nephropathy (Yu XQ et al., 2011), 9 SNPs IgE grass sensitization (Ramasamy A et al., 2011), 18 SNPs IgE levels (Granada M et al., 2011), 11 SNPs IgG levels (Liao M et al., 2012), 1 SNP Ileal carcinoids (Walsh et al., 2010), 4 SNPs Immune response to anthrax vaccine (Pajewski NM et al., 2012), 8 SNPs Immune response to smallpox vaccine (2 studies combined), 90 SNPs Immune response to smallpox vaccine (IL-6) (Kennedy RB et al., 2012), 53 SNPs Immune response to smallpox vaccine (IL-6) (Ovsyannikova IG et al., 2012), 37 SNPs Immunoglobulin A (Ferreira et al., 2010), 12 SNPs Inattentive symptoms (Lasky-Su et al., 2008), 48 SNPs Infantile hypertrophic pyloric stenosis (Feenstra B et al., 2012), 5 SNPs Inflammatory biomarkers (2 studies combined), 26 SNPs Inflammatory biomarkers (Aslibekyan S et al., 2012), 19 SNPs Inflammatory biomarkers (Naitza S et al., 2012), 7 SNPs Inflammatory bowel disease (4 studies combined), 14 SNPs Inflammatory bowel disease (Duerr et al., 2006), 3 SNPs Inflammatory bowel disease (early onset) (Imielinski et al., 2009), 4 SNPs Inflammatory bowel disease (Kugathasan et al., 2008), 6 SNPs Inflammatory bowel disease (Okada Y et al., 2011), 5 SNPs Information processing speed (Luciano et al., 2010), 25 SNPs Insomnia (caffeine-induced) (Byrne EM et al., 2012), 9 SNPs Insulin resistance/response (Irvin MR et al., 2011), 14 SNPs Insulin-like growth factors (Kaplan et al., 2011), 8 SNPs Insulin-related traits (Chen G et al., 2012), 6 SNPs Intelligence (Loo SK et al., 2012), 17 SNPs Interleukin-18 levels (He et al., 2010), 2 SNPs Interstitial lung disease (Nyberg F et al., 2011), 2 SNPs Intracranial aneurysm (4 studies combined), 13 SNPs Intracranial aneurysm (Bilguvar et al., 2008), 4 SNPs Intracranial aneurysm (Foroud T et al., 2012), 1 SNP Intracranial aneurysm (Low SK et al., 2012), 4 SNPs Intracranial aneurysm (Yasuno et al., 2010), 6 SNPs Intracranial volume (Ikram MA et al., 2012), 2 SNPs Intraocular pressure (van Koolwijk LM et al., 2012), 2 SNPs Iris characteristics (Larsson M et al., 2011), 7 SNPs Iris color (Kayser et al., 2008), 1 SNP Ischemic stroke (Gretarsdottir et al., 2008), 1 SNP Kawasaki disease (6 studies combined), 19 SNPs Kawasaki disease (Burgner et al., 2009), 2 SNPs Kawasaki disease (Khor CC et al., 2011), 2 SNPs Kawasaki disease (Kim et al., 2011), 2 SNPs Kawasaki disease (Lee YC et al., 2012), 6 SNPs Kawasaki disease (Onouchi Y et al., 2012), 5 SNPs Kawasaki disease (Tsai et al., 2011), 2 SNPs Keloid (Nakashima et al., 2010), 4 SNPs Kidney stones (Thorleifsson et al., 2009), 1 SNP Knee osteoarthritis (2 studies combined), 3 SNPs Knee osteoarthritis (Nakajima et al., 2010), 1 SNP Knee osteoarthritis (Valdes et al., 2008), 2 SNPs Large B-cell lymphoma (Kumar et al., 2011), 2 SNPs LDL cholesterol (5 studies combined), 7 SNPs LDL cholesterol (Burkhardt et al., 2008), 2 SNPs LDL cholesterol (Hiura et al., 2009), 1 SNP LDL cholesterol (Rasmussen-Torvik LJ et al., 2012), 1 SNP LDL cholesterol (Sandhu et al., 2008), 3 SNPs LDL cholesterol (Shen et al., 2010), 2 SNPs Lean body mass and age at menarche (combined) (Hai R et al., 2012), 1 SNP Left ventricular mass (2 studies combined), 3 SNPs Left ventricular mass (Arnett et al., 2009), 2 SNPs Left ventricular mass (Arnett et al., 2011), 3 SNPs Lentiform nucleus volume (Hibar DP et al., 2012), 14 SNPs Leprosy (2 studies combined), 10 SNPs Leprosy (Zhang et al., 2009), 6 SNPs Leprosy (Zhang F et al., 2011), 4 SNPs Life threatening arrhythmia (Murray SS et al., 2012), 2 SNPs Lipid levels in hepatitis C treatment (Clark PJ et al., 2012), 1 SNP Lipid traits (Surakka I et al., 2011), 1 SNP Lipoprotein-associated phospholipase A2 activity and mass (2 studies combined), 10 SNPs Lipoprotein-associated phospholipase A2 activity and mass (Grallert H et al., 2011), 7 SNPs Lipoprotein-associated phospholipase A2 activity and mass (Suchindran et al., 2010), 5 SNPs Liver enzyme levels (gamma-glutamyl transferase) (Chambers JC et al., 2011), 44 SNPs Longevity (5 studies combined), 70 SNPs Longevity (Malovini et al., 2011), 1 SNP Longevity (Nebel A et al., 2011), 1 SNP Longevity (Newman et al., 2010), 1 SNP Longevity (Sebastiani et al., 2010), 29 SNPs Longevity (Yashin AI et al., 2010), 39 SNPs Lp (a) levels (Qi Q et al., 2011), 4 SNPs Lumiracoxib-related liver injury (Singer et al., 2010), 1 SNP Lung adenocarcinoma (4 studies combined), 9 SNPs Lung adenocarcinoma (Hsiung et al., 2010), 1 SNP Lung adenocarcinoma (Landi et al., 2009), 5 SNPs Lung adenocarcinoma (Miki et al., 2010), 2 SNPs Lung adenocarcinoma (Shiraishi K et al., 2012), 4 SNPs Lung cancer (9 studies combined), 19 SNPs Lung cancer (Amos et al., 2008), 3 SNPs Lung cancer (Broderick et al., 2009), 7 SNPs Lung cancer (Hu Z et al., 2011), 4 SNPs Lung cancer (Hung et al., 2008), 1 SNP Lung cancer (Li et al., 2010), 1 SNP Lung cancer (Liu et al., 2008), 1 SNP Lung cancer (McKay et al., 2008), 2 SNPs Lung cancer (Timofeeva MN et al., 2012), 1 SNP Lung cancer (Wang et al., 2008), 3 SNPs Lung cancer-asbestos exposure interaction (Wei S et al., 2012), 2 SNPs Lymphocyte counts (Cusanovich DA et al., 2012), 2 SNPs Major CVD (Larson et al., 2007), 5 SNPs Major depressive disorder (9 studies combined), 40 SNPs Major depressive disorder (Aragam et al., 2011), 5 SNPs Major depressive disorder (broad) (Shyn et al., 2009), 9 SNPs Major depressive disorder (Kohli et al., 2011), 1 SNP Major depressive disorder (Lewis et al., 2010), 4 SNPs Major depressive disorder (Major Depressive Disorder Working Group of the Psychiatric G, 5 SNPs Major depressive disorder (Muglia et al., 2008), 1 SNP Major depressive disorder (Rietschel et al., 2010), 3 SNPs Major depressive disorder (Shi et al., 2010), 9 SNPs Major depressive disorder (Wray et al., 2010), 4 SNPs Major mood disorders (McMahon et al., 2010), 1 SNP Malaria (2 studies combined), 7 SNPs Malaria (Jallow et al., 2009), 3 SNPs Malaria (Timmann C et al., 2012), 4 SNPs Male infertility (Aston et al., 2009), 5 SNPs Male-pattern baldness (4 studies combined), 11 SNPs Male-pattern baldness (Brockschmidt FF et al., 2011), 2 SNPs Male-pattern baldness (Hillmer et al., 2008), 1 SNP Male-pattern baldness (Li R et al., 2012), 8 SNPs Male-pattern baldness (Richards et al., 2008), 2 SNPs Mammographic density (2 studies combined), 2 SNPs Mammographic density (Lindström et al., 2011), 1 SNP Mammographic density (Stevens KN et al., 2012), 1 SNP Mean platelet volume (4 studies combined), 38 SNPs Mean platelet volume (Meisinger et al., 2008), 3 SNPs Mean platelet volume (Qayyum R et al., 2012), 13 SNPs Mean platelet volume (Soranzo et al., 2009), 1 SNP Mean platelet volume (Soranzo et al., 2009), 27 SNPs Melanoma (6 studies combined), 17 SNPs Melanoma (Amos CI et al., 2011), 1 SNP Melanoma (Barrett JH et al., 2011), 10 SNPs Melanoma (Bishop et al., 2009), 5 SNPs Melanoma (Brown et al., 2008), 1 SNP Melanoma (Macgregor S et al., 2011), 2 SNPs Melanoma (Teerlink C et al., 2011), 1 SNP Menarche (4 studies combined), 44 SNPs Menarche (age at onset) (Elks et al., 2010), 42 SNPs Menarche (age at onset) (Ong et al., 2009), 1 SNP Menarche (age at onset) (Perry et al., 2009), 2 SNPs Menarche (age at onset) (Sulem et al., 2009), 1 SNP Menarche and menopause (age at onset) (He et al., 2009), 6 SNPs Meningioma (Dobbins SE et al., 2011), 1 SNP Meningococcal disease (Davila et al., 2010), 1 SNP Menopause (2 studies combined), 32 SNPs Menopause (age at onset) (Stolk et al., 2009), 13 SNPs Menopause (age at onset) (Stolk L et al., 2012), 19 SNPs Metabolic syndrome (2 studies combined), 40 SNPs Metabolic syndrome (Kristiansson K et al., 2012), 22 SNPs Metabolic syndrome (Zabaneh et al., 2010), 18 SNPs Metabolic traits (Suhre K et al., 2011), 37 SNPs Metabolite levels (3 studies combined), 64 SNPs Metabolite levels (Inouye M et al., 2012), 34 SNPs Metabolite levels (Kettunen J et al., 2012), 31 SNPs Metabolite levels (Nicholson G et al., 2011), 3 SNPs Migraine (4 studies combined), 14 SNPs Migraine (Anttila et al., 2010), 1 SNP Migraine (Chasman et al., 2011), 3 SNPs Migraine (Freilinger T et al., 2012), 10 SNPs Migraine (Ligthart et al., 2011), 2 SNPs Monocyte chemoattractant protein-1 (Voruganti VS et al., 2012), 3 SNPs Monocyte early outgrowth colony forming units (Shaw et al., 2011), 3 SNPs Morbidity-free survival (Lunetta et al., 2007), 15 SNPs Mortality among heart failure patients (Morrison et al., 2010), 11 SNPs Moyamoya disease (Kamada et al., 2010), 1 SNP Multiple myeloma (Broderick P et al., 2011), 3 SNPs Multiple sclerosis (14 studies combined), 112 SNPs Multiple sclerosis (Aulchenko et al., 2008), 1 SNP Multiple sclerosis (Bahlo et al., 2009), 8 SNPs Multiple sclerosis (Briggs et al., 2011), 6 SNPs Multiple sclerosis (Comabella et al., 2008), 1 SNP Multiple sclerosis (Hafler et al., 2007), 6 SNPs Multiple sclerosis (Jager et al., 2009), 15 SNPs Multiple sclerosis (Jakkula et al., 2010), 2 SNPs Multiple sclerosis (Martinelli-Boneschi F et al., 2012), 1 SNP Multiple sclerosis (Matesanz F et al., 2012), 1 SNP Multiple sclerosis (Nischwitz et al., 2010), 4 SNPs Multiple sclerosis (Patsopoulos NA et al., 2011), 19 SNPs Multiple sclerosis (Sanna et al., 2010), 2 SNPs Multiple sclerosis (Sawcer S et al., 2011), 55 SNPs Multiple sclerosis (Wang et al., 2011), 3 SNPs Multiple sclerosis--Brain Glutamate Levels (Baranzini et al., 2010), 5 SNPs Myasthenia gravis (Gregersen PK et al., 2012), 6 SNPs Myeloproliferative neoplasms (Kilpivaara et al., 2009), 1 SNP Myocardial infarction (3 studies combined), 11 SNPs Myocardial infarction (Aoki et al., 2010), 1 SNP Myocardial infarction (early onset) (Kathiresan et al., 2009), 9 SNPs Myocardial infarction (Helgadottir et al., 2007), 1 SNP Myopia (5 studies combined), 9 SNPs Myopia (pathological) (Fan Q et al., 2012), 4 SNPs Myopia (pathological) (Li et al., 2010), 1 SNP Myopia (pathological) (Li et al., 2011), 2 SNPs Myopia (pathological) (Nakanishi et al., 2009), 1 SNP Myopia (pathological) (Shi et al., 2011), 1 SNP N-glycan levels (Lauc et al., 2010), 8 SNPs Narcolepsy (3 studies combined), 3 SNPs Narcolepsy (Hallmayer et al., 2009), 1 SNP Narcolepsy (Hor et al., 2010), 2 SNPs Narcolepsy (Miyagawa et al., 2008), 1 SNP Nasopharyngeal carcinoma (3 studies combined), 11 SNPs Nasopharyngeal carcinoma (Bei et al., 2010), 7 SNPs Nasopharyngeal carcinoma (Ng et al., 2009), 1 SNP Nasopharyngeal carcinoma (Tse et al., 2009), 3 SNPs Natriuretic peptide levels (M et al., 2011), 3 SNPs Neonatal lupus (Clancy et al., 2010), 5 SNPs Nephrolithiasis (Urabe Y et al., 2012), 3 SNPs Nephropathy (3 studies combined), 8 SNPs Nephropathy (Feehally et al., 2010), 1 SNP Nephropathy (Gharavi et al., 2011), 5 SNPs Nephropathy (idiopathic membranous) (Stanescu et al., 2011), 2 SNPs Nephrotic syndrome (acquired) (Okamoto et al., 2011), 2 SNPs Neuranatomic and neurocognitive phenotypes (Carless et al., 2011), 1 SNP Neuroblastoma (4 studies combined), 10 SNPs Neuroblastoma (Diskin SJ et al., 2012), 6 SNPs Neuroblastoma (high-risk) (Capasso et al., 2009), 1 SNP Neuroblastoma (Maris et al., 2008), 1 SNP Neuroblastoma (Wang et al., 2010), 3 SNPs Neuroticism (3 studies combined), 7 SNPs Neuroticism (Calboli et al., 2010), 3 SNPs Neuroticism (Oord et al., 2008), 3 SNPs Neuroticism (Shifman et al., 2007), 1 SNP Neutrophil count (Okada et al., 2010), 2 SNPs Nevirapine-induced rash (Chantarangsu S et al., 2011), 3 SNPs Nicotine dependence (3 studies combined), 4 SNPs Nicotine dependence (Bierut et al., 2006), 2 SNPs Nicotine dependence (Rice JP et al., 2012), 1 SNP Nicotine dependence (Thorgeirsson et al., 2008), 1 SNP Nodular sclerosis Hodgkin lymphoma (Cozen W et al., 2011), 2 SNPs Non-albumin protein levels (Osman W et al., 2012), 5 SNPs Non-alcoholic fatty liver disease histology (other) (Chalasani et al., 2010), 35 SNPs Non-obstructive azoospermia (2 studies combined), 5 SNPs Non-obstructive azoospermia (Hu Z et al., 2011), 4 SNPs Non-obstructive azoospermia (Zhao H et al., 2012), 1 SNP Non-small cell lung cancer (3 studies combined), 7 SNPs Non-small cell lung cancer (Ahn MJ et al., 2011), 1 SNP Non-small cell lung cancer (Sato et al., 2010), 3 SNPs Non-small cell lung cancer (Yoon et al., 2010), 3 SNPs Nonalcoholic fatty liver disease (2 studies combined), 5 SNPs Nonalcoholic fatty liver disease (Kawaguchi T et al., 2012), 5 SNPs Nonalcoholic fatty liver disease (Speliotes et al., 2011), 1 SNP Nonsyndromic cleft lip with or without cleft palate (3 studies combined), 9 SNPs Nonsyndromic cleft lip with or without cleft palate (Birnbaum et al., 2009), 2 SNPs Nonsyndromic cleft lip with or without cleft palate (Grant et al., 2009), 2 SNPs Nonsyndromic cleft lip with or without cleft palate (Mangold et al., 2009), 6 SNPs Normalized brain volume (Baranzini et al., 2008), 38 SNPs Obesity (9 studies combined), 44 SNPs Obesity (Bradfield JP et al., 2012), 5 SNPs Obesity (Dorajoo et al., 2011), 1 SNP Obesity (early onset extreme) (Hinney et al., 2007), 1 SNP Obesity (extreme) (Cotsapas et al., 2009), 13 SNPs Obesity (extreme) (Paternoster L et al., 2011), 4 SNPs Obesity (extreme) (Scherag et al., 2010), 2 SNPs Obesity (Jiao H et al., 2011), 2 SNPs Obesity (Meyre et al., 2009), 5 SNPs Obesity (Wang et al., 2011), 14 SNPs Obesity and blood pressure (Melka MG et al., 2011), 5 SNPs Obesity and osteoporosis (Liu et al., 2009), 2 SNPs Obesity-related traits (Scuteri et al., 2007), 3 SNPs Obsessive-compulsive disorder (Stewart SE et al., 2012), 3 SNPs Optic disc parameters (Khor et al., 2011), 3 SNPs Optic disc size (rim) (Macgregor et al., 2010), 22 SNPs Orofacial clefts (2 studies combined), 41 SNPs Orofacial clefts (Ludwig KU et al., 2012), 31 SNPs Orofacial clefts (Shi M et al., 2012), 17 SNPs Osteoarthritis (5 studies combined), 8 SNPs Osteoarthritis (arcOGEN Consortium et al., 2012), 4 SNPs Osteoarthritis (Castano Betancourt MC et al., 2012), 1 SNP Osteoarthritis (Day-Williams AG et al., 2011), 1 SNP Osteoarthritis (Evangelou et al., 2010), 1 SNP Osteoarthritis (Kerkhof et al., 2010), 1 SNP Osteonecrosis of the jaw (Sarasquete et al., 2008), 1 SNP Osteoporosis (3 studies combined), 9 SNPs Osteoporosis (Guo et al., 2010), 1 SNP Osteoporosis (Hsu et al., 2010), 7 SNPs Osteoporosis (Kou et al., 2011), 1 SNP Osteoporosis-related phenotypes (Karasik et al., 2010), 1 SNP Other erythrocyte phenotypes (Ganesh et al., 2009), 45 SNPs Other metabolic traits (Sabatti et al., 2008), 23 SNPs Otosclerosis (Schrauwen et al., 2009), 1 SNP Ovarian cancer (3 studies combined), 10 SNPs Ovarian cancer (Bolton et al., 2010), 2 SNPs Ovarian cancer (Goode et al., 2010), 7 SNPs Ovarian cancer (Song et al., 2009), 1 SNP Ovarian reserve (Schuh-Huerta SM et al., 2011), 7 SNPs Paget's disease (2 studies combined), 11 SNPs Paget's disease (Albagha et al., 2010), 4 SNPs Paget's disease (Albagha et al., 2011), 9 SNPs Pain (2 studies combined), 4 SNPs Pain (Kim et al., 2009), 3 SNPs Pain (Peters MJ et al., 2012), 1 SNP Pancreatic cancer (4 studies combined), 32 SNPs Pancreatic cancer (Amundadottir et al., 2009), 1 SNP Pancreatic cancer (Low et al., 2010), 17 SNPs Pancreatic cancer (Petersen et al., 2010), 3 SNPs Pancreatic cancer (Wu C et al., 2011), 11 SNPs Panic disorder (Otowa et al., 2009), 17 SNPs Parkinson's disease (16 studies combined), 78 SNPs Parkinson's disease (age of onset) (Latourelle et al., 2009), 5 SNPs Parkinson's disease (Do CB et al., 2011), 10 SNPs Parkinson's disease (Edwards et al., 2010), 6 SNPs Parkinson's disease (familial) (Pankratz et al., 2008), 1 SNP Parkinson's disease (Fung et al., 2006), 3 SNPs Parkinson's disease (Hamza et al., 2010), 4 SNPs Parkinson's disease (Lill CM et al., 2012), 5 SNPs Parkinson's disease (Liu X et al., 2011), 3 SNPs Parkinson's disease (Maraganore et al., 2005), 1 SNP Parkinson's disease (motor and cognition) (Chung SJ et al., 2012), 5 SNPs Parkinson's disease (Nalls et al., 2011), 10 SNPs Parkinson's disease (Pankratz N et al., 2012), 17 SNPs Parkinson's disease (Saad et al., 2010), 3 SNPs Parkinson's disease (Satake et al., 2009), 4 SNPs Parkinson's disease (Simón-Sánchez et al., 2009), 10 SNPs Parkinson's disease (Spencer et al., 2010), 3 SNPs Partial epilepsies (KasperaviciĹ«te et al., 2010), 6 SNPs Pericardial fat (Fox CS et al., 2012), 1 SNP Periodontal microbiota (Divaris K et al., 2012), 16 SNPs Periodontitis (Schaefer et al., 2009), 1 SNP Peripheral artery disease (Koriyama et al., 2010), 2 SNPs Permanent tooth development (Geller F et al., 2011), 4 SNPs Personality dimensions (4 studies combined), 20 SNPs Personality dimensions (Alliey-Rodriguez et al., 2011), 7 SNPs Personality dimensions (Moor et al., 2010), 2 SNPs Personality dimensions (Terracciano et al., 2008), 5 SNPs Personality dimensions (Verweij et al., 2010), 7 SNPs Phospholipid levels (plasma) (Lemaitre RN et al., 2011), 50 SNPs Plasma C4b binding protein levels (Buil et al., 2010), 1 SNP Plasma carotenoid and tocopherol levels (Ferrucci et al., 2009), 2 SNPs Plasma chemerin levels (Bozaoglu et al., 2010), 7 SNPs Plasma coagulation factors (Smith et al., 2010), 2 SNPs Plasma E-selectin levels (Qi et al., 2010), 1 SNP Plasma eosinophil count (Gudbjartsson et al., 2009), 7 SNPs Plasma homocysteine (Paré et al., 2009), 2 SNPs Plasma level of vitamin B12 (Hazra et al., 2008), 1 SNP Plasma levels of liver enzymes (Yuan et al., 2008), 11 SNPs Plasma levels of Protein C (Tang et al., 2010), 4 SNPs Plasma Lp (a) levels (Ober et al., 2009), 1 SNP Plasminogen activator inhibitor type 1 levels (PAI-1) (Huang J et al., 2012), 4 SNPs Platelet aggregation (Johnson et al., 2010), 15 SNPs Platelet counts (2 studies combined), 84 SNPs Platelet counts (Gieger C et al., 2011), 54 SNPs Platelet counts (Ramsuran et al., 2011), 30 SNPs Platelet function and related traits (Guerrero et al., 2011), 1 SNP Polycystic ovary syndrome (2 studies combined), 13 SNPs Polycystic ovary syndrome (Chen et al., 2010), 5 SNPs Polycystic ovary syndrome (Shi Y et al., 2012), 11 SNPs PR interval (2 studies combined), 10 SNPs PR interval (Pfeufer et al., 2010), 9 SNPs PR interval (Smith et al., 2011), 1 SNP Premature ovarian failure (Qin Y et al., 2011), 1 SNP Primary biliary cirrhosis (4 studies combined), 33 SNPs Primary biliary cirrhosis (Hirschfield et al., 2009), 7 SNPs Primary biliary cirrhosis (Liu et al., 2010), 6 SNPs Primary biliary cirrhosis (Mells et al., 2011), 21 SNPs Primary biliary cirrhosis (Nakamura M et al., 2012), 7 SNPs Primary sclerosing cholangitis (Melum et al., 2010), 2 SNPs Primary tooth development (time to first tooth eruption) (Pillas et al., 2010), 15 SNPs Prion diseases (Mead S et al., 2011), 11 SNPs Progranulin levels (Carrasquillo et al., 2010), 1 SNP Progressive supranuclear palsy (Hoglinger GU et al., 2011), 11 SNPs Proinsulin levels (Strawbridge RJ et al., 2011), 10 SNPs Prostate cancer (19 studies combined), 142 SNPs Prostate cancer (Amin Al Olama A et al., 2012), 4 SNPs Prostate cancer (Cheng I et al., 2012), 8 SNPs Prostate cancer (Eeles et al., 2008), 12 SNPs Prostate cancer (Eeles et al., 2009), 19 SNPs Prostate cancer (gene x gene interaction) (Tao S et al., 2012), 51 SNPs Prostate cancer (Gudmundsson et al., 2007), 2 SNPs Prostate cancer (Gudmundsson et al., 2007), 2 SNPs Prostate cancer (Gudmundsson et al., 2008), 2 SNPs Prostate cancer (Gudmundsson et al., 2009), 8 SNPs Prostate cancer (Haiman et al., 2011), 1 SNP Prostate cancer (Kote-Jarai Z et al., 2011), 9 SNPs Prostate cancer (Murabito et al., 2007), 14 SNPs Prostate cancer (Nam RK et al., 2011), 2 SNPs Prostate cancer (Schumacher FR et al., 2011), 14 SNPs Prostate cancer (Sun et al., 2009), 1 SNP Prostate cancer (Takata et al., 2010), 11 SNPs Prostate cancer (Thomas et al., 2008), 7 SNPs Prostate cancer (Xu J et al., 2012), 3 SNPs Prostate cancer (Yeager et al., 2007), 2 SNPs Protein biomarker (de Boer RA et al., 2012), 2 SNPs Protein quantitative trait loci (Melzer et al., 2008), 49 SNPs Prothrombin time (Tang W et al., 2012), 11 SNPs Psoriasis (7 studies combined), 38 SNPs Psoriasis (Capon et al., 2008), 2 SNPs Psoriasis (Ellinghaus et al., 2010), 3 SNPs Psoriasis (Liu et al., 2008), 3 SNPs Psoriasis (Nair et al., 2009), 8 SNPs Psoriasis (Strange et al., 2010), 17 SNPs Psoriasis (Stuart et al., 2010), 8 SNPs Psoriasis (Zhang et al., 2009), 3 SNPs Psoriatic arthritis (2 studies combined), 5 SNPs Psoriatic arthritis (Ellinghaus E et al., 2011), 2 SNPs Psoriatic arthritis (Hüffmeier et al., 2010), 3 SNPs Pulmonary function (3 studies combined), 44 SNPs Pulmonary function (Hancock et al., 2009), 8 SNPs Pulmonary function (Repapi et al., 2009), 7 SNPs Pulmonary function (Soler Artigas M et al., 2011), 33 SNPs Pulmonary function decline (Imboden M et al., 2012), 39 SNPs Pulmonary function measures (Wilk et al., 2009), 1 SNP Pulmonary function traits (other) (Wilk et al., 2007), 12 SNPs QT interval (5 studies combined), 27 SNPs QT interval (Arking et al., 2006), 1 SNP QT interval (Kim JW et al., 2012), 3 SNPs QT interval (Newton-Cheh et al., 2009), 13 SNPs QT interval (Nolte et al., 2009), 2 SNPs QT interval (Pfeufer et al., 2009), 12 SNPs Quantitative traits (Lowe et al., 2009), 33 SNPs Radiation response (Niu et al., 2010), 12 SNPs Recombination rate (males) (Kong et al., 2008), 2 SNPs Red blood cell traits (Kullo et al., 2010), 13 SNPs Refractive error (2 studies combined), 2 SNPs Refractive error (Hysi et al., 2010), 1 SNP Refractive error (Solouki et al., 2010), 1 SNP Renal cell carcinoma (2 studies combined), 6 SNPs Renal cell carcinoma (Purdue et al., 2010), 3 SNPs Renal cell carcinoma (Wu X et al., 2011), 3 SNPs Renal function and chronic kidney disease (Köttgen et al., 2009), 4 SNPs Renal function-related traits (urea) (Okada Y et al., 2012), 38 SNPs Renal sinus fat (Foster MC et al., 2011), 8 SNPs Resistin levels (Qi Q et al., 2012), 4 SNPs Response to acetaminophen (hepatotoxicity) (Moyer et al., 2010), 5 SNPs Response to amphetamines (Hart AB et al., 2012), 52 SNPs Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic the, 25 SNPs Response to antidepressant treatment (Clark SL et al., 2011), 22 SNPs Response to antidepressants (2 studies combined), 8 SNPs Response to antidepressants (Sasayama D et al., 2012), 1 SNP Response to antidepressants (Uher et al., 2010), 8 SNPs Response to antineoplastic agents (Wade et al., 2011), 9 SNPs Response to antipsychotic therapy (2 studies combined), 18 SNPs Response to antipsychotic therapy (extrapyramidal side effects) (Aberg et al., 2009), 17 SNPs Response to antipsychotic therapy (extrapyramidal side effects) (Drago A et al., 2011), 1 SNP Response to antipsychotic treatment (3 studies combined), 47 SNPs Response to antipsychotic treatment (Adkins et al., 2010), 37 SNPs Response to antipsychotic treatment (Alkelai et al., 2009), 1 SNP Response to antipsychotic treatment (McClay et al., 2009), 9 SNPs Response to cerivastatin (Marciante et al., 2011), 1 SNP Response to citalopram treatment (2 studies combined), 18 SNPs Response to citalopram treatment (Adkins DE et al., 2012), 17 SNPs Response to citalopram treatment (Garriock et al., 2009), 7 SNPs Response to clopidogrel therapy (Shuldiner et al., 2009), 1 SNP Response to diuretic therapy (Turner et al., 2008), 1 SNP Response to fenofibrate (Frazier-Wood AC et al., 2012), 10 SNPs Response to gemcitabine in pancreatic cancer (2 studies combined), 5 SNPs Response to gemcitabine in pancreatic cancer (Innocenti F et al., 2011), 3 SNPs Response to gemcitabine in pancreatic cancer (Kiyotani K et al., 2012), 2 SNPs Response to hepatitis C treatment (6 studies combined), 15 SNPs Response to hepatitis C treatment (Ge et al., 2009), 3 SNPs Response to hepatitis C treatment (Lange CM et al., 2011), 9 SNPs Response to hepatitis C treatment (Ochi et al., 2011), 1 SNP Response to hepatitis C treatment (Suppiah et al., 2009), 1 SNP Response to hepatitis C treatment (Tanaka et al., 2009), 1 SNP Response to hepatitis C treatment (Tanaka et al., 2011), 4 SNPs Response to iloperidone treatment (QT prolongation) (Volpi et al., 2008), 6 SNPs Response to interferon beta therapy (Weber et al., 2011), 2 SNPs Response to irinotecan in non-small-cell lung cancer (Han JY et al., 2012), 2 SNPs Response to metformin (2 studies combined), 1 SNPs Response to metformin (Florez JC et al., 2011), 1 SNP Response to metformin (Zhou et al., 2010), 1 SNP Response to platinum-based agents (Won HH et al., 2011), 3 SNPs Response to platinum-based chemotherapy in non-small-cell lung cancer (2 studies combined), 5 SNPs Response to platinum-based chemotherapy in non-small-cell lung cancer (Hu L et al., 201, 5 SNPs Response to platinum-based chemotherapy in non-small-cell lung cancer (Wu et al., 2011), 1 SNP Response to statin therapy (5 studies combined), 46 SNPs Response to statin therapy (Barber et al., 2010), 36 SNPs Response to statin therapy (Deshmukh HA et al., 2012), 1 SNP Response to statin therapy (LDL-C) (Chasman DI et al., 2012), 8 SNPs Response to statin therapy (Link et al., 2008), 1 SNP Response to statin therapy (Shiffman D et al., 2012), 1 SNP Response to tamoxifen in breast cancer (Kiyotani K et al., 2011), 1 SNP Response to taxane treatment (placlitaxel) (Niu N M D Ph D et al., 2012), 29 SNPs Response to TNF antagonist treatment (Liu et al., 2008), 8 SNPs Response to TNF-alpha inhibitors in rheumatoid arthritis (Krintel SB et al., 2012), 8 SNPs Response to tocilizumab in rheumatoid arthritis (Wang J et al., 2012), 28 SNPs Response to treatment for acute lymphoblastic leukemia (Yang et al., 2009), 12 SNPs Response to Vitamin E supplementation (Major JM et al., 2012), 8 SNPs Resting heart rate (Eijgelsheim et al., 2010), 10 SNPs Restless legs syndrome (4 studies combined), 9 SNPs Restless legs syndrome (Schormair et al., 2008), 2 SNPs Restless legs syndrome (Stefansson et al., 2007), 1 SNP Restless legs syndrome (Winkelmann et al., 2007), 3 SNPs Restless legs syndrome (Winkelmann J et al., 2011), 6 SNPs Retinal vascular caliber (Ikram et al., 2010), 5 SNPs Retinol levels (Mondul AM et al., 2011), 2 SNPs Rheumatoid arthritis (13 studies combined), 74 SNPs Rheumatoid arthritis (Eleftherohorinou et al., 2011), 5 SNPs Rheumatoid arthritis (Freudenberg et al., 2011), 9 SNPs Rheumatoid arthritis (Gregersen et al., 2009), 5 SNPs Rheumatoid arthritis (Hu HJ et al., 2011), 1 SNP Rheumatoid arthritis (Juliŕ et al., 2008), 2 SNPs Rheumatoid arthritis (Kochi et al., 2010), 4 SNPs Rheumatoid arthritis (Myouzen K et al., 2012), 2 SNPs Rheumatoid arthritis (Okada Y et al., 2012), 15 SNPs Rheumatoid arthritis (Plenge et al., 2007), 2 SNPs Rheumatoid arthritis (Plenge et al., 2007), 3 SNPs Rheumatoid arthritis (Raychaudhuri et al., 2008), 9 SNPs Rheumatoid arthritis (Stahl et al., 2010), 29 SNPs Rheumatoid arthritis (Terao et al., 2011), 3 SNPs Ribavirin-induced anemia (Ochi et al., 2010), 1 SNP RR interval (heart rate) (Marroni et al., 2009), 34 SNPs Sarcoidosis (2 studies combined), 3 SNPs Sarcoidosis (Fischer A et al., 2012), 1 SNP Sarcoidosis (Hofmann S et al., 2012), 2 SNPs Schizophrenia (18 studies combined), 95 SNPs Schizophrenia (Alkelai A et al., 2011), 2 SNPs Schizophrenia (Athanasiu et al., 2010), 3 SNPs Schizophrenia (Bergen SE et al., 2012), 32 SNPs Schizophrenia (Irish Schizophrenia Genomics Consortium & the Wellcome Trust Case Contro, 2 SNPs Schizophrenia (Kirov et al., 2008), 1 SNP Schizophrenia (Lencz et al., 2007), 1 SNP Schizophrenia (Levinson DF et al., 2012), 11 SNPs Schizophrenia (Ma X et al., 2011), 1 SNP Schizophrenia (O'Donovan et al., 2008), 3 SNPs Schizophrenia (Purcell et al., 2009), 4 SNPs Schizophrenia (Ripke S et al., 2011), 25 SNPs Schizophrenia (Shi et al., 2009), 2 SNPs Schizophrenia (Shi Y et al., 2011), 2 SNPs Schizophrenia (Shifman et al., 2008), 1 SNP Schizophrenia (Stefansson et al., 2009), 7 SNPs Schizophrenia (Sullivan et al., 2008), 6 SNPs Schizophrenia (treatment refractory) (Liou YJ et al., 2012), 2 SNPs Schizophrenia (Yue WH et al., 2011), 2 SNPs Schizophrenia, bipolar disorder and depression (combined) (Huang et al., 2010), 5 SNPs Sclerosing cholangitis and ulcerative colitis (combined) (Ellinghaus D et al., 2012), 2 SNPs Scoliosis (2 studies combined), 2 SNPs Scoliosis (Sharma et al., 2011), 1 SNP Scoliosis (Takahashi Y et al., 2011), 1 SNP Select biomarker traits (Benjamin et al., 2007), 21 SNPs Self-rated health (Mosing et al., 2010), 10 SNPs Serum bilirubin levels (Johnson et al., 2009), 8 SNPs Serum calcium (2 studies combined), 11 SNPs Serum calcium (Kapur et al., 2010), 1 SNP Serum calcium (O'Seaghdha et al., 2010), 10 SNPs Serum creatinine (Chambers et al., 2010), 5 SNPs Serum dehydroepiandrosterone sulphate levels (Zhai et al., 2011), 8 SNPs Serum IgE levels (Weidinger et al., 2008), 2 SNPs Serum iron levels (2 studies combined), 5 SNPs Serum iron levels (Pichler et al., 2011), 5 SNPs Serum iron levels (Tanaka et al., 2009), 1 SNP Serum magnesium levels (Meyer et al., 2010), 9 SNPs Serum markers of iron status (3 studies combined), 28 SNPs Serum markers of iron status (Benyamin et al., 2008), 27 SNPs Serum markers of iron status (Benyamin et al., 2009), 4 SNPs Serum markers of iron status (Oexle et al., 2010), 5 SNPs Serum matrix metalloproteinase (Cheng et al., 2009), 4 SNPs Serum metabolites (2 studies combined), 21 SNPs Serum metabolites (Gieger et al., 2008), 16 SNPs Serum metabolites (Illig et al., 2009), 5 SNPs Serum phosphorus levels (Kestenbaum et al., 2010), 5 SNPs Serum phytosterol levels (Teupser et al., 2010), 3 SNPs Serum prostate-specific antigen levels (Gudmundsson et al., 2010), 7 SNPs Serum soluble E-selectin (Paterson et al., 2009), 1 SNP Serum total protein level (Franceschini N et al., 2012), 28 SNPs Serum urate (6 studies combined), 17 SNPs Serum urate (Dehghan et al., 2008), 3 SNPs Serum urate (Döring et al., 2008), 1 SNP Serum urate (Li et al., 2007), 1 SNP Serum urate (Vitart et al., 2008), 1 SNP Serum urate (Wallace et al., 2008), 4 SNPs Serum urate (Yang et al., 2010), 11 SNPs Serum uric acid (3 studies combined), 24 SNPs Serum uric acid (Charles et al., 2011), 8 SNPs Serum uric acid (Kolz et al., 2009), 11 SNPs Serum uric acid (McArdle et al., 2008), 7 SNPs Sex hormone-binding globulin levels (Coviello AD et al., 2012), 30 SNPs Sexual dysfunction (2 studies combined), 8 SNPs Sexual dysfunction (female) (Burri A et al., 2012), 3 SNPs Sexual dysfunction (SSRI/SNRI-related) (Kurose K et al., 2012), 5 SNPs Skin pigmentation (Stokowski et al., 2007), 3 SNPs Skin sensitivity to sun (2 studies combined), 10 SNPs Skin sensitivity to sun (Sulem et al., 2007), 14 SNPs Skin sensitivity to sun (Sulem et al., 2008), 6 SNPs Sleepiness (Gottlieb et al., 2007), 4 SNPs Small-cell lung cancer (Wu et al., 2010), 1 SNP Smoking behavior (7 studies combined), 41 SNPs Smoking behavior (Caporaso et al., 2009), 21 SNPs Smoking behavior (David SP et al., 2012), 5 SNPs Smoking behavior (Genetics et al., 2010), 5 SNPs Smoking behavior (Kumasaka N et al., 2012), 3 SNPs Smoking behavior (Liu et al., 2010), 1 SNP Smoking behavior (Thorgeirsson et al., 2010), 5 SNPs Smoking behavior (Yoon D et al., 2011), 6 SNPs Smoking cessation (Uhl et al., 2010), 1 SNP Soluble ICAM-1 (2 studies combined), 4 SNPs Soluble ICAM-1 (Paré et al., 2008), 4 SNPs Soluble ICAM-1 (Paré et al., 2011), 3 SNPs Soluble leptin receptor levels (Sun et al., 2010), 1 SNP Soluble levels of adhesion molecules (Barbalic et al., 2010), 5 SNPs Speech perception in dyslexia (Roeske et al., 2009), 2 SNPs Sphingolipid levels (2 studies combined), 38 SNPs Sphingolipid levels (Demirkan A et al., 2012), 35 SNPs Sphingolipid levels (Hicks et al., 2009), 5 SNPs Stevens-Johnson syndrome and toxic epidermal necrolysis (2 studies combined), 5 SNPs Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) (Genin E et al., 2011, 4 SNPs Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) (Tohkin M et al., 201, 1 SNP Stroke (6 studies combined), 16 SNPs Stroke (Bellenguez C et al., 2012), 1 SNP Stroke (Ikram et al., 2009), 1 SNP Stroke (ischemic) (Holliday EG et al., 2012), 1 SNP Stroke (ischemic) (Traylor M et al., 2012), 8 SNPs Stroke (Matarín et al., 2007), 4 SNPs Stroke (pediatric) (Arning A et al., 2012), 4 SNPs Subclinical atherosclerosis traits (other) (O'Donnell et al., 2007), 11 SNPs Substance dependence (Chen X et al., 2011), 1 SNP Sudden cardiac arrest (2 studies combined), 50 SNPs Sudden cardiac arrest (Aouizerat BE et al., 2011), 50 SNPs Sudden cardiac arrest (Arking DE et al., 2011), 1 SNP Suicidal ideation (Perroud et al., 2010), 4 SNPs Suicide attempts in bipolar disorder (Willour et al., 2011), 3 SNPs Systemic lupus erythematosus (10 studies combined), 66 SNPs Systemic lupus erythematosus (Chung et al., 2011), 24 SNPs Systemic lupus erythematosus (Graham et al., 2008), 8 SNPs Systemic lupus erythematosus (Han et al., 2009), 18 SNPs Systemic lupus erythematosus (Harley et al., 2008), 6 SNPs Systemic lupus erythematosus (Hom et al., 2008), 9 SNPs Systemic lupus erythematosus (Kozyrev et al., 2008), 1 SNP Systemic lupus erythematosus (Lee YH et al., 2012), 5 SNPs Systemic lupus erythematosus (Okada Y et al., 2012), 2 SNPs Systemic lupus erythematosus (Yang et al., 2010), 1 SNP Systemic lupus erythematosus (Yang et al., 2010), 2 SNPs Systemic sclerosis (3 studies combined), 18 SNPs Systemic sclerosis (Allanore Y et al., 2011), 7 SNPs Systemic sclerosis (Gorlova O et al., 2011), 18 SNPs Systemic sclerosis (Radstake et al., 2010), 4 SNPs Systolic blood pressure (3 studies combined), 41 SNPs Systolic blood pressure (Ehret GB et al., 2011), 50 SNPs Systolic blood pressure (Levy et al., 2009), 18 SNPs Systolic blood pressure (Newton-Cheh et al., 2009), 9 SNPs T-tau (Han et al., 2010), 17 SNPs Tanning (Nan et al., 2009), 10 SNPs Tardive dyskinesia (Tanaka S et al., 2011), 1 SNP Telomere length (6 studies combined), 14 SNPs Telomere length (Codd et al., 2010), 1 SNP Telomere length (Gu et al., 2011), 4 SNPs Telomere length (Levy et al., 2010), 4 SNPs Telomere length (Mangino et al., 2009), 1 SNP Telomere length (Mangino M et al., 2012), 4 SNPs Telomere length (Prescott et al., 2011), 1 SNP Temperament (2 studies combined), 29 SNPs Temperament (bipolar disorder) (Greenwood TA et al., 2012), 13 SNPs Temperament (Service SK et al., 2012), 16 SNPs Testicular cancer (2 studies combined), 3 SNPs Testicular cancer (Kanetsky et al., 2009), 1 SNP Testicular cancer (Kanetsky et al., 2011), 2 SNPs Testicular germ cell cancer (Turnbull et al., 2010), 6 SNPs Testicular germ cell tumor (Rapley et al., 2009), 6 SNPs Testosterone levels (2 studies combined), 23 SNPs Testosterone levels (Ohlsson C et al., 2011), 2 SNPs Testosterone levels (Prescott J et al., 2012), 21 SNPs Thoracic aortic aneurysms and dissections (Lemaire SA et al., 2011), 1 SNP Thyroid cancer (2 studies combined), 5 SNPs Thyroid cancer (Gudmundsson et al., 2009), 2 SNPs Thyroid cancer (Gudmundsson J et al., 2012), 3 SNPs Thyroid function (Rawal R et al., 2012), 4 SNPs Thyroid volume (Teumer et al., 2011), 8 SNPs Thyrotoxic hypokalemic periodic paralysis (2 studies combined), 2 SNPs Thyrotoxic hypokalemic periodic paralysis (Cheung CL et al., 2012), 1 SNP Thyrotoxic hypokalemic periodic paralysis (Jongjaroenprasert W et al., 2012), 1 SNP Tonometry (Levy et al., 2007), 22 SNPs Total ventricular volume (Furney et al., 2010), 38 SNPs Tourette syndrome (Scharf JM et al., 2012), 7 SNPs Treatment response for severe sepsis (Man M et al., 2012), 8 SNPs Triglycerides (9 studies combined), 140 SNPs Triglycerides (Aulchenko et al., 2008), 45 SNPs Triglycerides (Kathiresan et al., 2008), 22 SNPs Triglycerides (Kathiresan et al., 2008), 36 SNPs Triglycerides (Kim YJ et al., 2011), 39 SNPs Triglycerides (Kooner et al., 2008), 4 SNPs Triglycerides (Pollin et al., 2008), 1 SNP Triglycerides (Tan A et al., 2011), 3 SNPs Triglycerides (Waterworth et al., 2010), 34 SNPs Triglycerides (Willer et al., 2008), 26 SNPs Tuberculosis (2 studies combined), 15 SNPs Tuberculosis (Thye et al., 2010), 14 SNPs Tuberculosis (Thye T et al., 2012), 1 SNP Two-hour glucose challenge (Saxena et al., 2010), 5 SNPs Type 1 diabetes (8 studies combined), 70 SNPs Type 1 diabetes (Barrett et al., 2009), 38 SNPs Type 1 diabetes (Bradfield JP et al., 2011), 9 SNPs Type 1 diabetes (Cooper et al., 2008), 14 SNPs Type 1 diabetes (Grant et al., 2008), 5 SNPs Type 1 diabetes (Hakonarson et al., 2007), 4 SNPs Type 1 diabetes (Hakonarson et al., 2008), 1 SNP Type 1 diabetes (Todd et al., 2007), 12 SNPs Type 1 diabetes (Wallace et al., 2009), 2 SNPs Type 1 diabetes autoantibodies (Plagnol V et al., 2011), 23 SNPs Type 1 diabetes nephropathy (Sandholm N et al., 2012), 11 SNPs Type 2 diabetes (29 studies combined), 180 SNPs Type 2 diabetes ( et al., 2007), 50 SNPs Type 2 diabetes (Below et al., 2011), 1 SNP Type 2 diabetes (Cho YS et al., 2011), 10 SNPs Type 2 diabetes (Cui B et al., 2011), 2 SNPs Type 2 diabetes (Huang J et al., 2012), 4 SNPs Type 2 diabetes (Imamura M et al., 2012), 4 SNPs Type 2 diabetes (Kho AN et al., 2011), 1 SNP Type 2 diabetes (Kooner JS et al., 2011), 6 SNPs Type 2 diabetes (Li H et al., 2012), 10 SNPs Type 2 diabetes (Palmer ND et al., 2012), 4 SNPs Type 2 diabetes (Parra et al., 2011), 5 SNPs Type 2 diabetes (Perry JR et al., 2012), 12 SNPs Type 2 diabetes (Qi et al., 2010), 1 SNP Type 2 diabetes (Salonen et al., 2007), 2 SNPs Type 2 diabetes (Saxena et al., 2007), 13 SNPs Type 2 diabetes (Scott et al., 2007), 10 SNPs Type 2 diabetes (Shu et al., 2010), 4 SNPs Type 2 diabetes (Sim et al., 2011), 17 SNPs Type 2 diabetes (Sladek et al., 2007), 3 SNPs Type 2 diabetes (Steinthorsdottir et al., 2007), 3 SNPs Type 2 diabetes (Takeuchi et al., 2009), 7 SNPs Type 2 diabetes (Timpson et al., 2008), 8 SNPs Type 2 diabetes (Tsai et al., 2010), 3 SNPs Type 2 diabetes (Unoki et al., 2008), 3 SNPs Type 2 diabetes (Voight et al., 2010), 26 SNPs Type 2 diabetes (Yamauchi et al., 2010), 1 SNP Type 2 diabetes (Yasuda et al., 2008), 1 SNP Type 2 diabetes (Zeggini et al., 2007), 10 SNPs Type 2 diabetes (Zeggini et al., 2008), 16 SNPs Type 2 diabetes and other traits (Rung et al., 2009), 6 SNPs Ulcerative colitis (7 studies combined), 85 SNPs Ulcerative colitis (Anderson et al., 2011), 47 SNPs Ulcerative colitis (Asano et al., 2009), 7 SNPs Ulcerative colitis (Barrett et al., 2009), 13 SNPs Ulcerative colitis (Franke et al., 2008), 2 SNPs Ulcerative colitis (Franke et al., 2010), 6 SNPs Ulcerative colitis (McGovern et al., 2010), 19 SNPs Ulcerative colitis (Silverberg et al., 2009), 12 SNPs Upper aerodigestive tract cancers (McKay et al., 2011), 5 SNPs Urate levels (Tin A et al., 2011), 5 SNPs Uric acid levels (Karns R et al., 2012), 6 SNPs Urinary albumin excretion (2 studies combined), 7 SNPs Urinary albumin excretion (Böger et al., 2011), 1 SNP Urinary albumin excretion (Hwang et al., 2007), 6 SNPs Urinary bladder cancer (2 studies combined), 3 SNPs Urinary bladder cancer (Kiemeney et al., 2008), 2 SNPs Urinary bladder cancer (Kiemeney et al., 2010), 3 SNPs Urinary metabolites (Suhre et al., 2011), 5 SNPs Uterine fibroids (Cha et al., 2011), 5 SNPs Vaccine-related adverse events (Miller et al., 2011), 2 SNPs Vascular endothelial growth factor levels (Debette S et al., 2011), 4 SNPs Vaspin levels (Breitfeld J et al., 2012), 1 SNP Venous thromboembolism (3 studies combined), 9 SNPs Venous thromboembolism (Germain M et al., 2011), 4 SNPs Venous thromboembolism (Heit JA et al., 2012), 5 SNPs Venous thromboembolism (Trégouët et al., 2009), 1 SNP Ventricular conduction (Sotoodehnia et al., 2010), 25 SNPs Vertical cup-disc ratio (Ramdas et al., 2010), 12 SNPs Visceral fat (Fox CS et al., 2012), 53 SNPs Vitamin B12 levels (Lin X et al., 2012), 6 SNPs Vitamin D insufficiency (Wang et al., 2010), 3 SNPs Vitamin D levels (2 studies combined), 3 SNPs Vitamin D levels (Ahn et al., 2010), 3 SNPs Vitamin D levels (Lasky-Su J et al., 2012), 1 SNP Vitamin E levels (Major JM et al., 2011), 3 SNPs Vitiligo (6 studies combined), 37 SNPs Vitiligo (Birlea et al., 2009), 4 SNPs Vitiligo (Jin et al., 2010), 10 SNPs Vitiligo (Jin et al., 2011), 1 SNP Vitiligo (Jin Y et al., 2012), 14 SNPs Vitiligo (Quan et al., 2010), 4 SNPs Vitiligo (Tang XF et al., 2012), 4 SNPs Volumetric brain MRI (Seshadri et al., 2007), 19 SNPs vWF and FVIII levels (Antoni G et al., 2011), 11 SNPs Waist circumference (2 studies combined), 12 SNPs Waist circumference (Fox et al., 2007), 5 SNPs Waist circumference (Heard-Costa et al., 2009), 7 SNPs Waist Circumference - Triglycerides (WC-TG) (Kraja et al., 2011), 42 SNPs Waist circumference and related phenotypes (Chambers et al., 2008), 4 SNPs Waist-hip ratio (Heid et al., 2010), 17 SNPs Warfarin maintenance dose (3 studies combined), 10 SNPs Warfarin maintenance dose (Cha et al., 2010), 5 SNPs Warfarin maintenance dose (Cooper et al., 2008), 3 SNPs Warfarin maintenance dose (Takeuchi et al., 2009), 4 SNPs Weight (3 studies combined), 58 SNPs Weight (Croteau-Chonka et al., 2010), 28 SNPs Weight (Johansson et al., 2009), 19 SNPs Weight (Thorleifsson et al., 2008), 31 SNPs White blood cell count (2 studies combined), 5 SNPs White blood cell count (Crosslin DR et al., 2011), 3 SNPs White blood cell count (Reiner AP et al., 2011), 2 SNPs White blood cell types (Okada Y et al., 2011), 20 SNPs White matter hyperintensity burden (Fornage M et al., 2011), 2 SNPs White matter integrity (Lopez LM et al., 2012), 2 SNPs Wilms tumor (Turnbull C et al., 2012), 7 SNPs Working memory (McClay et al., 2010), 23 SNPs Wrist bone mass (Tan et al., 2010), 1 SNP YKL-40 levels (Ober et al., 2008), 1 SNP 
